Metagenomi Therapeutics (MGX) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the CEO, with legal counsel recording minutes and formal business outlined in the notice and proxy statement.

• Directors, executive team, audit firm representatives, and outside counsel were welcomed.

• Rules of conduct and procedures for voting and submitting questions were explained to stockholders.

Corporate governance

• Inspector of Election appointed to tabulate voting results, with quorum confirmed as present.

• Voting conducted via proxy and virtual platform, with polls opened for eligible stockholders.

Board and executive committee updates

• Two nominees, Juergen Eckhardt and Eric Bjerkholt, were put forward for election as Class II Directors for a three-year term.

• No additional director nominations were received from stockholders.